Skip to main content
. Author manuscript; available in PMC: 2016 Sep 1.
Published in final edited form as: J Urol. 2015 Mar 14;194(3):804–811. doi: 10.1016/j.juro.2015.02.2944

Figure 3.

Figure 3

Bladder permeability assessments were collected at 1-5 days after urinary-bladder infusion of protamine sulfate. The urinary bladder TEER was significantly decreased from protamine sulfate-treated rats on day 1 (A) and day 3 (B), but was not significantly different from controls by day 5 (C). The macromolecular flux of FITC-dextran across the urinary bladder from protamine sulfate-treated rats was significantly increased at all time points (D-F) (*p<0.05; **p<0.01; ***p<0.001; ****p<0.0001 ) compared to controls. At each time point, rats n = 5-7/group were used.